SCHEMBL6980255

SCHEMBL6980255

COc1ccc(-c2sc3cc(OC)ccc3c2C(=O)c2ccc(OCCC3CCCCC3)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 14/20 0.70
ESR2 Q92731 14/20 0.70
ENPP3 O14638 3/20 0.59
ENPP1 P22413 2/20 0.59
TUBB4A P04350 1/20 0.55
TUBB P07437 1/20 0.55
TUBA3C P0DPH7 1/20 0.55
TUBA1B P68363 1/20 0.55
TUBA4A P68366 1/20 0.55
TUBB4B P68371 1/20 0.55
TUBB3 Q13509 1/20 0.55
TUBB2A Q13885 1/20 0.55
TUBB8 Q3ZCM7 1/20 0.55
TUBA3E Q6PEY2 1/20 0.55
TUBA1A Q71U36 1/20 0.55
TUBA1C Q9BQE3 1/20 0.55
TUBB6 Q9BUF5 1/20 0.55
TUBB2B Q9BVA1 1/20 0.55
TUBB1 Q9H4B7 1/20 0.55
CNR1 P21554 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6979219 0.87 ESR1 (0.70) ESR1ESR2CNR1MEN1ALDH1A1
SCHEMBL6773068 0.87 ESR1 (0.66) ESR1ESR2ENPP3ENPP1TUBB4A
Hydrochloric Acid SCHEMBL6767144 0.86 ESR1 (0.67) ESR1ESR2ENPP3ENPP1TUBB4A
SCHEMBL7971668 0.86 ESR1 (0.67) ESR1ESR2ENPP3ENPP1TUBB4A
SCHEMBL7970907 0.85 ESR1 (0.73) ESR1ESR2ENPP3ENPP1TUBB4A
SCHEMBL6967393 0.84 ESR1 (0.71) ESR1ESR2ENPP3ENPP1TUBB4A
SCHEMBL6980679 0.84 ESR1 (0.71) ESR1ESR2ENPP3ENPP1TUBB4A
SCHEMBL1665661 0.83 ESR1 (1.00) ESR1ESR2ENPP3ENPP1CNR1
SCHEMBL23113126 0.83 ESR1 (0.70) ESR1ESR2ENPP3ENPP1TUBB4A
SCHEMBL8519077 0.83 ESR1 (0.70) ESR1ESR2ENPP3ENPP1TUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832888-B1 Benzothiophene compounds, compositions, and methods LILLY CO ELI (US) 2003-07-23 EP disclosed
US-5981570-A INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS, INCLUDING HYPERLIPIDEMIA. ELI LILLY AND COMPANY (US) 1999-11-09 US disclosed